ArticleFrontiers in immunology2026
ClareV: a contrastive learning framework for context-aware TRBV representations in TCR repertoires.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: V gene segments of the T cell receptor (TCR) Methods: We introduce ClareV, a contrastive learning framework that partitions T cell receptor repertoires into V gene-specific groups to extract data-driven embeddings capturing these dynamics. We evaluated ClareV across three TCR repertoire cohorts spanning cytomegalovirus (CMV), gastric cancer, and multi-cancer settings. Results: In the Emerson2017 CMV cohort, the ClareV Random Forest (RF) Fusion model improved AUC by 14.3% over the strongest V-family usage-only baseline (linear SVM) and by 13.3% over the strongest V-gene usage-only baseline (Random Forest). These results indicate that ClareV embeddings capture additional repertoire-level information beyond V-frequency summaries. Ablation studies showed that frequency-weighted bagging and contrastive V-bag learning both contributed to performance, outperforming simple pooling and non-contrastive learned-bag controls. In the CMV cohort, downstream embedding analyses showed that ClareV representations partially recapitulated IMGT-defined V-gene structure while retaining a CMV-responsive, non-sequence component that was largely orthogonal to classical V-usage signals. Discussion: These findings support adaptive V-gene representations as a compact feature space that complements V-frequency summaries for repertoire-level classification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.